معرفی
Maximilian Anderla is a researcher affiliated with the Faculty of Chemistry at an unspecified university, specifically associated with the Institute of Inorganic Chemistry. His work focuses on pharmacology, oncology, and radiochemistry, contributing to the development of radiolabeled compounds for tumor imaging and treatment.
- Research Interests: Metabolic stabilization of peptides, triazole/carboxamide modifications, radiotracers (Gallium-68, Indium-111), and xenograft models in cancer imaging.
- Key Contributions: Investigates molecular strategies for enhancing the clinical utility of radiolabeled peptides, aligning with UN Sustainable Development Goals (SDGs) in health and sustainability.
- Recent Publications: 2022 studies on CRC imaging and peptide stabilization; 2025 publication (future) suggests ongoing research in tracer development.
- Activities: Participated in scientific lectures on Auger electron therapy and CRC imaging applications (2021–2022).
۰مقاله منتشرشده
